StockData
Phibro Animal Health Corp logo

Phibro Animal Health Corp (PAHC) stock

PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$34.92−0.10 (-0.29%)

Close on Nov 17, 2026Market cap $1.42BP/E 14.4Yield 1.37%

Phibro Animal Health ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Phibro Animal Health's ebitda for the twelve months ending Jun 30, 2026 was $245.91M, up 57.6% year over year. For fiscal 2026 it was $245.91M, up 57.6% from the year before. Over ten years it grew 8.5% a year on average. The highest annual figure on record is $245.91M in fiscal 2026.

Annual ebitda

PeriodPeriod endValueChange
FY2026Jun 30, 2026$245.91M+57.6%
FY2025Jun 30, 2025$156.07M+74.4%
FY2024Jun 30, 2024$89.49M-15.5%
FY2023Jun 30, 2023$105.86M-5.2%
FY2022Jun 30, 2022$111.69M+4.6%
FY2021Jun 30, 2021$106.75M+5.1%
FY2020Jun 30, 2020$101.54M-8.4%
FY2019Jun 30, 2019$110.79M-12.0%
FY2018Jun 30, 2018$125.87M+1.6%
FY2017Jun 30, 2017$123.94M+13.5%
FY2016Jun 30, 2016$109.20M-0.1%
FY2015Jun 30, 2015$109.27M+28.2%
FY2014Jun 30, 2014$85.25M+12.5%
FY2013Jun 30, 2013$75.75M+13.3%
FY2012Jun 30, 2012$66.85M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$61.50M+33.3%
Q3 FY2026CQ1 2026Mar 31, 2026$57.10M+23.8%
Q2 FY2026CQ4 2025Dec 31, 2025$63.22M+70.4%
Q1 FY2026CQ3 2025Sep 30, 2025$64.09M+140.0%
Q4 FY2025CQ2 2025Jun 30, 2025$46.13M+67.0%
Q3 FY2025CQ1 2025Mar 31, 2025$46.13M+58.4%
Q2 FY2025CQ4 2024Dec 31, 2024$37.11M+50.8%
Q1 FY2025CQ3 2024Sep 30, 2024$26.70M+227.8%
Q4 FY2024CQ2 2024Jun 30, 2024$27.62M-14.6%
Q3 FY2024CQ1 2024Mar 31, 2024$29.12M+7.7%
Q2 FY2024CQ4 2023Dec 31, 2023$24.61M+1.1%
Q1 FY2024CQ3 2023Sep 30, 2023$8.15M-63.2%
Q4 FY2023CQ2 2023Jun 30, 2023$32.34M+3.4%
Q3 FY2023CQ1 2023Mar 31, 2023$27.04M-2.2%
Q2 FY2023CQ4 2022Dec 31, 2022$24.34M-19.6%
Q1 FY2023CQ3 2022Sep 30, 2022$22.13M-1.5%
Q4 FY2022CQ2 2022Jun 30, 2022$31.29M+15.9%
Q3 FY2022CQ1 2022Mar 31, 2022$27.64M-1.5%
Q2 FY2022CQ4 2021Dec 31, 2021$30.30M+8.3%
Q1 FY2022CQ3 2021Sep 30, 2021$22.47M-5.3%
Q4 FY2021CQ2 2021Jun 30, 2021$27.00M+2.7%
Q3 FY2021CQ1 2021Mar 31, 2021$28.05M-5.1%
Q2 FY2021CQ4 2020Dec 31, 2020$27.98M+0.8%
Q1 FY2021CQ3 2020Sep 30, 2020$23.72M+32.3%
Q4 FY2020CQ2 2020Jun 30, 2020$26.28M+36.5%
Q3 FY2020CQ1 2020Mar 31, 2020$29.57M+0.4%
Q2 FY2020CQ4 2019Dec 31, 2019$27.76M-14.7%
Q1 FY2020CQ3 2019Sep 30, 2019$17.93M-39.3%
Q4 FY2019CQ2 2019Jun 30, 2019$19.26M-41.7%
Q3 FY2019CQ1 2019Mar 31, 2019$29.44M-11.4%
Q2 FY2019CQ4 2018Dec 31, 2018$32.55M+6.5%
Q1 FY2019CQ3 2018Sep 30, 2018$29.54M+1.8%
Q4 FY2018CQ2 2018Jun 30, 2018$33.03M+10.4%
Q3 FY2018CQ1 2018Mar 31, 2018$33.24M-9.7%
Q2 FY2018CQ4 2017Dec 31, 2017$30.57M+5.1%
Q1 FY2018CQ3 2017Sep 30, 2017$29.03M+3.2%
Q4 FY2017CQ2 2017Jun 30, 2017$29.92M–
Q3 FY2017CQ1 2017Mar 31, 2017$36.82M–
Q2 FY2017CQ4 2016Dec 31, 2016$29.07M–
Q1 FY2017CQ3 2016Sep 30, 2016$28.13M–

More Phibro Animal Health figures

See a number that looks wrong?